Factors influencing treatment frequency of continuation ECT in schizophrenia

Journal of ECT

Volumn 17, Issue 3, 2001, Pages 190-194

  Chanpattana, Worrawat ^a   Chakrabhand, M L Somchai ^b  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

^b Ministry of Health   (Thailand)

Author keywords

Electroconvulsive therapy; Frequency of continuation electroconvulsive therapy; Prognostic factors

Indexed keywords

FLUPENTIXOL; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCONVULSIVE THERAPY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; PROGNOSIS; RATING SCALE; SCHIZOPHRENIA; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; CHRONIC DISEASE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; PROGNOSIS; RECURRENCE; RISK FACTORS; SCHIZOPHRENIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 0034850934     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124509-200109000-00008     Document Type: Article

References (43)

1. Un nuovo metodo di shockterapie "L'elettroshock"
2. The maintenance treatment of chronic psychotics by electrically induced convulsions
3. Electric convulsive therapy, with emphasis on importance of adequate treatment
4. Maintenance ECT: A survey of practice
5. Continuation ECT in treatment-resistant schizophrenia: A controlled study
6. Guidelines for long-term use of electroconvulsive therapy
7. Continuation therapy following ECT: Directions for future research
8. Ambulatory electroconvulsive therapy: Report of a Task Force of the Association for Convulsive Therapy
9. Continuation ECT: A review
10. The Brief Psychiatric Rating Scale
11. Seizure threshold in electroconvulsive therapy. Effects of sex, age, electrode placement, and number of treatments
12. Seizure threshold in electroconvulsive therapy. I. Initial seizure threshold
13. Continuation ECT in schizophrenia: A pilot study
14. Maintenance ECT in schizophrenia: A pilot study
15. The use of stabilization period in ECT research in schizophrenia: A pilot study
16. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia
17. Assessment of the differences in MMSE between neurological, psychiatric patients and normal population
18. Cognitive deficits in schizophrenia
19. Cognitive function in schizophrenic patients
20. Cerebral ventricular size and cognitive impairment in chronic schizophrenia
21. Schizophrenic syndromes, cognitive performance, and neurological dysfunction
22. Intellectual deficits in first-episode schizophrenia: Evidence for progressive deterioration
23. Medical Research Council: Clinical trial of the depressive illness
24. Drug resistant depression: Response to ECT
25. Medication resistance and clinical response to electroconvulsive therapy
26. Electroconvulsive therapy in the treatment-resistant patient
27. Results with electroconvulsive therapy in 200 cases of schizophrenia
28. Prognostic variables for electro-shock therapy
29. ECT for schizophrenia
30. ECT-chlorpromazine and chlorpromazine compared in the treatment of schizophrenia
31. ECT/chlorpromazine combination versus chlorpromazine alone in acutely schizophrenic patients
32. ECT combined with neuroleptics in the treatment of schizophrenia
33. High dose haloperidol therapy: Its effectiveness and a comparison with electroconvulsive therapy
34. Combined electroconvulsive and neuroleptic therapy in schizophrenia refractory to neuroleptic
35. Electroconvulsive therapy and neuroleptic medication in therapy-resistant positive-symptom psychosis
36. Electroconvulsive therapy and schizophrenia
37. Convulsive therapy in schizophrenia?